"The Metabolic Response to Fructose Ingestion," "Underlying Causes of Male Hypogonadism," "Characterization of Somatotroph Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1," and "Bone Health in Patients with CDH1 Mutations."

Needs Statement

Physicians, fellows, residents, physician assistants, nurse practitioners, nurses, and other healthcare professionals need to receive regular updates on professional guidelines, advances in basic science and clinical research, and emerging treatment modalities and management strategies for patients with endocrine disorders. The series will explore new models of multidisciplinary care in the field, especially as it relates to patients with cardiometabolic diseases such as obesity and diabetes. The series aims to expand the knowledge of learners, promote adherence to evidence-based guidelines, enhance the quality of endocrinology care, disseminate best clinical practices, and improve patient outcomes.

Target Audience

Physicians, medical students, fellows, residents, nurses, and other health professionals.

Learning Objectives

The Metabolic Response to Fructose Ingestion
At the conclusion of the activity, the participants should be able to:
  • Evaluate the metabolic impact of fructose ingestion.
  • Compare the effects of fructose and glucose on circulating factors.
  • Assess research design and methodology in nutritional studies.
  • Identify potential risks and benefits in nutritional intervention studies.
Underlying Causes of Male Hypogonadism
At the conclusion of the activity, the participants should be able to:
  • Examine the current guideline recommendations for treatment of male hypogonadism.
  • Review additional contributing factors for male hypogonadism.
  • Appraise gaps in current practice.
Characterization of Somatotroph Pituitary Adenomas in Multiple Endocrine Neoplasia Type 1
At the conclusion of the activity, the participants should be able to:
  • Outline the historical connection between multiple endocrine neoplasia and somatotroph adenomas.
  • Identify the value in differentiating between genetically diagnosed and clinically diagnosed multiple endocrine neoplasia syndromes.
  • Describe the methods by which cases will be catalogued in an MEN1 database.
Bone Health in Patients with CDH1 Mutations
At the conclusion of the activity, the participants should be able to:
  • Identify the need to assess bone health in patients with hereditary gastric carcinoma.
  • Manage bone health in patients with a CDH1 mutation.
  • Recognized the increased risk of lobular breast cancer in patients with a CDH1 mutation.
  • Describe the effects of gastrectomy on bone health.
Course summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Course opens: 
09/01/2024
Course expires: 
09/30/2026
Cost:
$1.00
Rating: 
0
Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
 
Baylor College of Medicine designates this enduring material activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Price

Cost:
$1.00
Please login or register to take this course.

Thank you for reviewing this Baylor College of Medicine on-demand activity. In order to complete the evaluation and claim credit for your participation, please select the appropriate payment option above. After payment has been completed, you will receive an email confirmation and receipt. 

For any questions, contact cpd@bcm.edu.